4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001714899-21-000114
President and CEO sold 18,333 shares at an average $44.92 ($823,581)
From the SEC's structured data for this filing
Trades in this filing
Watts Ryan J. · President and CEO
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-12-01 | Sale : show line 1 in the form | −8,516 | $44.39 | $378,025 | 2,113,185 | I |
| 2021-12-01 | Sale : show line 2 in the form | −9,012 | $45.30 | $408,244 | 2,104,173 | I |
| 2021-12-01 | Sale : show line 3 in the form | −805 | $46.35 | $37,312 | 2,103,368 | I |
| Open-market sales · 18,333 sh · avg $44.92 · $823,581 | ||||||
Loading xslF345X03/wf-form4_163856660331306.xml…